Questa Capital Management
VC Fund
San Francisco, United States
Questa Capital Management is a healthcare venture growth equity firm investing in breakout growth companies.
- Total investments:
- 54
- Last investment:
- Lead investor:
- 69%
- Fund size:
- $397M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Questa Capital Management invests in
Health CareMedicalMedical DeviceInformation TechnologySoftware
Stages Questa Capital Management invests in
Series BFunding RoundSeries CSeries ASeries D
Countries Questa Capital Management invests in
United StatesCanadaUnited Kingdom
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 22 (41%)
- Medical 8 (15%)
- Medical Device 8 (15%)
- Information Technology 6 (11%)
- Software 5 (9%)
Stage
- Series B 13 (24%)
- Funding Round 8 (15%)
- Series C 7 (13%)
- Series A 5 (9%)
- Series D 5 (9%)
Country
- United States 22 (41%)
- Canada 2 (4%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Aabed Meer
Partner
|
Partner | Total investments: 4 | Find email | |
Bradley Sloan
Managing Partner
|
Managing Partner | Total investments: 2 | Find email | |
Bradley Sloan
Managing Partner
|
Managing Partner | Total investments: 5 | Find email | |
Brian L. Butler
Vice President
|
Vice President | Total investments: 2 | Find email | |
Ryan Drant
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 42 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Calyxo
|
Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today. Founded in 2016, Calyxo is led by executives and investors with a strong track record of commercializing paradigm-shifting solutions in thefield of urology. Our team features some of the most talented, high-achieving and brightest minds in the medical device industry who are compelled by a desire to make a difference in kidney stone care. We are proud of our collaborative, diverse, fun and dynamic culture. | $40M / Series F / Apr 14, 2026 | |
EnsoData
|
EnsoData is a startup that utilizes artificial intelligence to analyze the human body to diagnose health conditions. EnsoData, whose software uses machine learning algorithms to help clinicians score sleep data and diagnose patients with sleep apnea and other disorders, has now realized that dream—and then some. EnsoData's autoscoringalgorithm combines AASM scoring best practices with cutting edge machine learning algorithms that learn and adapt to every single patient. | $20M / Series B / Jun 25, 2025 | |
Bicycle Health
|
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become anaddiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients.Ankit Gupta established it in San Francisco, California in 2017. | $16.5M / Jan 29, 2025 | |
|
Bicycle Health
|
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become anaddiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients.Ankit Gupta established it in San Francisco, California in 2017. | $16.5M / Jan 29, 2025 | |
Aerin Medical
|
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | $32.5M / Private Equity / Jan 13, 2025 | |
|
Aerin Medical
|
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | Jan 13, 2025 | |
|
Aerin Medical
|
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, andeffectively. | $32.5M / Jan 13, 2025 | |
Ossio
|
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now. | $27.6M / Series D / Dec 02, 2024 | |
ACTO
|
ACTO is an omnichannel education platform for life sciences companies. ACTO is an AI-powered SaaS platform built for life sciences that uses mobile experiences and agency partnerships to give learners all the tools they need in one intuitive cross-platform app, and give leaders powerful admin tools with engagement data in one command center. | $7.4M / Venture - Series Unknown / Sep 12, 2024 | |
Eko Health
|
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detectearlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com. | $41M / Series D / Jun 05, 2024 | |
| See all 54 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Medical Investors
18,848 investors
Medical Device Investors
11,047 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
FAQ
What does Questa Capital Management invest in?
Questa Capital Management invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Funding Round stage. Most of the 54 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Questa Capital Management?
Public channels for Questa Capital Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Questa Capital Management?
The team at Questa Capital Management includes Aabed Meer (Partner), Bradley Sloan (Managing Partner) and Bradley Sloan (Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
